drugs
New dopamine agonists which       may have a levodopa "sparing effect;" it has been suggested that some of the       drugs should be considered as first line treatments for newly diagnosed       Parkinson's disease patients.
New dopamine agonists which       may have a levodopa "sparing effect;" it has been suggested that some of the        @SUBJECT$  should be considered as first line  @PREDICAT$  for newly diagnosed       Parkinson's disease  @OBJECT$ .